AdvisorShares Psychedelic... (PSIL)
NYSEArca: PSIL
· リアルタイム株価 · USD
25.25
-0.18 (-0.71%)
終値時点： Aug 13, 2026, 3:51 PM
25.85
+2.25%
時間外: 4:21 PM
AdvisorShares Psychedelics ETF (PSIL) ETF Price, Holdings & Analysis
-0.71% (1D)
| 買気配 | 24.88 |
| 時価総額 | n/a |
| 純資産総額 | 48.53M |
| 基準価額 | 24.72 |
| ベータ | 0.56 |
| EPS（過去12か月） | n/a |
| PER（過去12か月） | n/a |
| 発行済口数 | n/a |
| 設定日 | Sep 15, 2021 |
| 売気配 | 25.42 |
| 出来高 | 14,257 |
| 平均出来高（20日） | 38,470 |
| 始値 | 25.39 |
| 前日終値 | 25.43 |
| 日中値幅 | 25.25 - 25.66 |
| 52週の値幅 | 15.36 - 25.73 |
| 組入銘柄 | n/a |
| 経費率 | 1.00% |
PSILについて
The fund is an actively managed ETF that seeks to achieve its investment objective by investing, under normal circumstances, at least 80% of its net assets (plus any borrowings for investment purposes) in securities of companies that derive at least 50% of their net revenue from or devote 50% of their assets to psychedelic drugs and derivatives that have economic characteristics similar to such securities. The fund primarily invests in publicly listed life sciences companies focused on psychedelic medicines as well as other companies with activities in the psychedelics business. The fund is non-diversified.
上位10銘柄 純資産の70.03%
| 名称 | シンボル | 構成比 |
|---|---|---|
| Ataibeckley Inc | ATAI | 14.15% |
| Definium Therapeutic... | DFTX | 12.05% |
| Compass Pathways PLC... | CMPS | 9.83% |
| Helus Pharma Inc Ord... | HELP.NE | 5.47% |
| Relmada Therapeutics... | RLMD | 5.32% |
| Gh Research PLC | GHRS | 4.82% |
| Nrx Pharmaceuticals ... | NRXP | 4.74% |
| Neurocrine Bioscienc... | NBIX | 4.66% |
| Alto Neuroscience In... | ANRO | 4.55% |
| Bright Minds Bioscie... | DRUG.CN | 4.44% |
分配金 分配金利回り 7.44%
| 権利落ち日 | 金額 | 支払日 |
|---|---|---|
| Dec 22, 2025 | $1.6840 | n/a |
| Sep 22, 2025 | $0.0200 | n/a |
| Jun 23, 2025 | $0.0120 | n/a |
| Mar 21, 2025 | $0.1630 | n/a |
| Dec 23, 2024 | $0.0550 | n/a |
